Science Explorer Back to mapMap
Discussion
Company · Watertown · United States

Forma Therapeutics (United States)

formatherapeutics.comROR OpenAlex
Research works
75
▼ 37% vs 2018-21
Citations
4.4k
58.7 per fractional work
Top-10% rate
16.5%
all institutions 10.0%
Open access
54%
world 40%
International
19%
world 18%
Forma Therapeutics (United States)

Not ranked overall: Forma Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Forma Therapeutics (United States) work in?

In all years, 49% of research at Forma Therapeutics (United States) is in Life Sciences, 35% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (40%), Medicine (34%), Immunology and Microbiology (6%). It does 2.8× the world's share of Life Sciences.

Life Sciences: 37 fractional works · 48.6% of its workBiochemistry, Genetics and Molecular Biology: 30 fractional works · 40.4% of its workMolecular Biology: 23 fractional works · 30.8% of its workCancer Research: 2 fractional works · 2.7% of its workCell Biology: 2 fractional works · 2.7% of its workGenetics: 1 fractional works · 1.3% of its workBiochemistry: 1 fractional works · 1.1% of its workPhysiology: 1 fractional works · 0.9% of its workBiotechnology: 0 fractional works · 0.4% of its workBiophysics: 0 fractional works · 0.2% of its workImmunology and Microbiology: 4 fractional works · 5.9% of its workImmunology: 4 fractional works · 5.9% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 1.3% of its workPharmaceutical Science: 1 fractional works · 0.8% of its workToxicology: 0 fractional works · 0.3% of its workPharmacology: 0 fractional works · 0.2% of its workNeuroscience: 1 fractional works · 0.9% of its workCellular and Molecular Neuroscience: 1 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 0 fractional works · 0.1% of its workHealth Sciences: 26 fractional works · 35.1% of its workMedicine: 25 fractional works · 33.5% of its workOncology: 6 fractional works · 8.0% of its workGenetics: 3 fractional works · 4.0% of its workGeriatrics and Gerontology: 3 fractional works · 4.0% of its workHematology: 3 fractional works · 3.3% of its workEpidemiology: 2 fractional works · 2.4% of its workPulmonary and Respiratory Medicine: 2 fractional works · 2.1% of its workPhysiology: 1 fractional works · 2.0% of its workPathology and Forensic Medicine: 1 fractional works · 1.6% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.1% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.6% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.6% of its workRehabilitation: 0 fractional works · 0.6% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.4% of its workReproductive Medicine: 0 fractional works · 0.4% of its workInfectious Diseases: 0 fractional works · 0.3% of its workPharmacology: 0 fractional works · 0.3% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.2% of its workSurgery: 0 fractional works · 0.2% of its workComplementary and alternative medicine: 0 fractional works · 0.2% of its workFamily Practice: 0 fractional works · 0.2% of its workHepatology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.6% of its workHealth Professions: 1 fractional works · 1.0% of its workGeneral Health Professions: 0 fractional works · 0.5% of its workSpeech and Hearing: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workVeterinary: 0 fractional works · 0.4% of its workSmall Animals: 0 fractional works · 0.4% of its workNursing: 0 fractional works · 0.1% of its workPhysical Sciences: 9 fractional works · 12.3% of its workChemistry: 4 fractional works · 5.7% of its workOrganic Chemistry: 3 fractional works · 4.2% of its workPhysical and Theoretical Chemistry: 1 fractional works · 0.9% of its workSpectroscopy: 0 fractional works · 0.7% of its workComputer Science: 2 fractional works · 2.9% of its workComputational Theory and Mathematics: 2 fractional works · 2.0% of its workArtificial Intelligence: 1 fractional works · 0.9% of its workEngineering: 2 fractional works · 2.0% of its workElectrical and Electronic Engineering: 1 fractional works · 1.8% of its workBiomedical Engineering: 0 fractional works · 0.2% of its workMaterials Science: 1 fractional works · 1.6% of its workMaterials Chemistry: 1 fractional works · 1.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMathematics: 0 fractional works · 0.1% of its workSocial Sciences: 3 fractional works · 4.0% of its workSocial Sciences: 1 fractional works · 1.4% of its workDemography: 1 fractional works · 1.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workArts and Humanities: 1 fractional works · 1.3% of its workHistory and Philosophy of Science: 1 fractional works · 1.3% of its workPsychology: 1 fractional works · 0.7% of its workClinical Psychology: 1 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.5% of its workEconomics and Econometrics: 0 fractional works · 0.5% of its workALL ITS WORKFormaTherapeutics…75fractional works, all years
Life Sciences49%Physical Sciences12%Health Sciences35%Social Sciences4%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 18 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology3040.4%
    2. Immunology and Microbiology45.9%
    3. Pharmacology, Toxicology and Pharmaceutics11.3%
    4. Neuroscience10.9%
    5. Agricultural and Biological Sciences00.1%
    1. Medicine2533.5%
    2. Health Professions11.0%
    3. Veterinary00.4%
    4. Nursing00.1%
    1. Chemistry45.7%
    2. Computer Science22.9%
    3. Engineering22.0%
    4. Materials Science11.6%
    5. Mathematics00.1%
    1. Social Sciences11.4%
    2. Arts and Humanities11.3%
    3. Psychology10.7%
    4. Economics, Econometrics and Finance00.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.14× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.06× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 13.70× its world share, 2 worksImmunology and Micro…Neuroscience: 1.20× its world share, 0 worksNeuroscienceComputer Science: 0.53× its world share, 1 worksComputer ScienceEngineering: 0.55× its world share, 1 worksEngineeringHealth Professions: 1.04× its world share, 0 worksHealth ProfessionsMedicine: 2.45× its world share, 8 worksMedicineNursing: 1.40× its world share, 0 worksNursingEconomics, Econometrics and Finance: 1.12× its world share, 0 worksEconomics, Econometr…Psychology: 0.70× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 13.7×. Every wedge is a field page.

All 11 fields, with their numbers
  1. Immunology and Microbiology13.70×2 works
  2. Biochemistry, Genetics and Molecular Biology3.06×3 works
  3. Medicine2.45×8 works
  4. Nursing1.40×0 works
  5. Neuroscience1.20×0 works
  6. Economics, Econometrics and Finance1.12×0 works
  7. Health Professions1.04×0 works
  8. Psychology0.70×0 works
  9. Engineering0.55×1 works
  10. Computer Science0.53×1 works
  11. Agricultural and Biological Sciences0.14×0 works

Who are the top researchers at Forma Therapeutics (United States)?

Ranked on the quality score, Jason Oeh, Adeela Kamal and Thomas O’Brien lead among researchers whose main affiliation is Forma Therapeutics (United States).

  1. 1 Jason Oeh United States · #369,248 worldwide 2.4k citations · 98 works
  2. 2 Adeela Kamal United States · #447,727 worldwide 6.1k citations · 96 works
  3. 3 Thomas O’Brien United States · #472,905 worldwide 4.2k citations · 78 works
  4. 4 Wei Lu United States · #949,760 worldwide 1.9k citations · 46 works
  5. 5 Sanjeev Forsyth United States · #971,199 worldwide 420 citations · 17 works
  6. 6 Xiaozhang Zheng United States · #1,069,897 worldwide 1.6k citations · 58 works
  7. 7 Julie A. Brevard United States · #1,106,810 worldwide 986 citations · 33 works
  8. 8 Bingsong Han United States · #1,216,215 worldwide 714 citations · 18 works
  9. 9 Gregg A. Timony United States · #1,236,117 worldwide 1.2k citations · 27 works
  10. 10 Maria D. Ribadeneira United States · #1,270,285 worldwide 1.1k citations · 34 works
All ranked researchers at Forma Therapeutics (United States)

What are the most cited papers from Forma Therapeutics (United States)?

The most cited paper from Forma Therapeutics (United States) is "A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors" (Adeela Kamal, Lia Thao, John Sensintaffar et al., 2003), with 1,396 citations. Next come "Molecular basis of USP7 inhibition by selective small-molecule inhibitors" (483) and "BI-3406, a Potent and Selective SOS1–KRAS Interaction Inhibitor, Is Effective in KRAS-Driven Cancers through Combined MEK Inhibition" (432).

Most cited papers
#PaperReleasedCitations
1 A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors Adeela Kamal, Lia Thao, John Sensintaffar et al. · Nature Sep 2003 1,396
2 Molecular basis of USP7 inhibition by selective small-molecule inhibitors A.P. Turnbull et al. · Nature Open access Oct 2017 483
3 BI-3406, a Potent and Selective SOS1–KRAS Interaction Inhibitor, Is Effective in KRAS-Driven Cancers through Combined MEK Inhibition Marco H. Hofmann et al. · Cancer Discovery Open access 19 Aug 2020 432
4 Targeting multiple signal transduction pathways through inhibition of Hsp90 Hong Zhang, Francis J. Burrows · Journal of Molecular Medicine 26 May 2004 375
5 HIF‐dependent induction of adenosine A2B receptor in hypoxia Tianqing Kong, Karen A. Westerman, Marion Faigle et al. · The FASEB Journal 31 Oct 2006 335
All 62 most cited papers, with filters and sorting

Which keywords describe research at Forma Therapeutics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Therapy, Innate Immunity, Protein Folding, Proteostasis, Heat Shock Proteins, Molecular Chaperones, Apoptosis and Metabolism.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer Therapy15▲ 32×11 topics
  2. Innate Immunity7▲ 25×3 topics
  3. Protein Folding6▲ 164×2 topics
  4. Proteostasis6▲ 165×2 topics
  5. Heat Shock Proteins6▲ 352×1 topic
  6. Molecular Chaperones6▲ 249×1 topic
  7. Oxidative Stress5▲ 3.4×14 topics
  8. Apoptosis4▲ 14×7 topics
  9. Metabolism4▲ 7.9×7 topics
  10. Immunotherapy4▲ 7.3×5 topics
  11. Cancer4▲ 3.3×16 topics
  12. Mitochondria3▲ 27×3 topics
  13. Transcriptional Regulation3▲ 17×6 topics
  14. Enzyme Regulation3▲ 86×1 topic
  15. Nucleotide Metabolism3▲ 119×1 topic
  16. Aging3▲ 7.9×4 topics
  17. Longevity3▲ 52×2 topics
  18. Medicinal Chemistry3▲ 10×5 topics
  19. Resveratrol3▲ 297×1 topic
  20. Sirtuins3▲ 297×1 topic
  21. Targeted Therapy3▲ 17×5 topics
  22. Cell Death3▲ 18×4 topics
  23. Proteasome Inhibitors3▲ 51×2 topics
  24. Cancer Immunotherapy2▲ 22×2 topics
  25. BET Bromodomains2▲ 141×1 topic
  26. PROTACs2▲ 141×1 topic
  27. Synthesis2▲ 4.7×4 topics
  28. Drug Discovery2▲ 6.4×5 topics
  29. Epigenetic Regulation2▲ 12×2 topics
  30. Homologous Recombination2▲ 37×2 topics
  31. Immunotoxin2▲ 77×1 topic
  32. Lymphoma2▲ 16×2 topics
  33. Ricin Poisoning2▲ 77×1 topic
  34. BRCA Mutation2▲ 132×1 topic
  35. CAR T Cells2▲ 51×1 topic
  36. Chimeric Antigen Receptor2▲ 51×1 topic
  37. DNA Repair2▲ 96×2 topics
  38. PARP Inhibitors2▲ 132×1 topic
  39. Genetic Regulation2▲ 12×2 topics
  40. HDAC Inhibitors2▲ 107×1 topic

Which research topics does Forma Therapeutics (United States) publish most on?

By volume in 2022-now: CAR-T cell therapy research, Immune Cell Function and Interaction, Hemoglobinopathies and Related Disorders and Ferroelectric and Negative Capacitance Devices.

CAR-T cell therapy research: 1 fractional worksImmune Cell Function and Interaction: 1 fractional worksHemoglobinopathies and Related Disorders: 1 fractional worksFerroelectric and Negative Capacitance Devices: 1 fractional worksAdvanced Memory and Neural Computing: 1 fractional worksImmunotherapy and Immune Responses: 1 fractional worksProtein Degradation and …1Protein Degradation and Inhibitors: 1 fractional worksNeural Networks and Rese…1Neural Networks and Reservoir Computing: 1 fractional worksCancer-related Molecular…0Cancer-related Molecular Pathways: 0 fractional worksProstate Cancer Treatmen…0Prostate Cancer Treatment and Research: 0 fractional works
OncologyImmunologyGeneticsElectrical and Electronic Engineering3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 1 works
  2. 2 Immune Cell Function and Interaction Immunology 1 works
  3. 3 Hemoglobinopathies and Related Disorders Genetics 1 works
  4. 4 Ferroelectric and Negative Capacitance Devices Electrical and Electronic Engineering 1 works
  5. 5 Advanced Memory and Neural Computing Electrical and Electronic Engineering 1 works
  6. 6 Immunotherapy and Immune Responses Immunology 1 works
  7. 7 Protein Degradation and Inhibitors Molecular Biology 1 works
  8. 8 Neural Networks and Reservoir Computing Artificial Intelligence 1 works
  9. 9 Cancer-related Molecular Pathways Oncology 0 works
  10. 10 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available53.5%not open46.5%

World: 40% of research is openly available.

with international co-authors19.2%domestic only80.8%

World: 18% is written across borders.

How has Forma Therapeutics (United States)'s research output changed?

Output in 2022-2025 was 37% lower than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Forma Therapeutics (United States) as a percentage of every work published that year, 0.000049% in 2024.

still counting0.00020%0.00040%0.00060%Forma Therapeutics (United States)0.000046% in 202520102020

Fractional works of Forma Therapeutics (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Watertown

All research institutions in Watertown

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Forma Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.